Suboptimal cytoreduction in ovarian carcinoma is associated with molecular pathways characteristic of increased

Zhenqiu Liu1, Jessica A Beach2, Hasmik Agadjanian3

  • 1Biostatistics and Bioinformatics Research Center, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

Gynecologic Oncology
|September 9, 2015
PubMed
Abstract

Insights

Suboptimal cytoreductive surgery in advanced epithelial ovarian cancer (EOC) is linked to poor survival. Tumor biology, specifically increased stromal activation and invasiveness, appears to dictate surgical success rather than surgical effort alone.

Area of Science:

  • Gynecologic Oncology
  • Surgical Oncology
  • Molecular Biology

Background:

  • Suboptimal cytoreductive surgery in advanced epithelial ovarian cancer (EOC) correlates with reduced patient survival.
  • The reasons for suboptimal resection remain unclear, with debate on whether it stems from tumor biology or surgical limitations.

Purpose of the Study:

  • To identify molecular pathways and cell types contributing to suboptimal surgical resection in EOC.
  • To elucidate the biological factors influencing the success of cytoreductive surgery.

Main Methods:

  • Comparative gene expression analysis between optimally and suboptimally cytoreduced EOC patients.
  • Identification of gene networks associated with suboptimal cytoreduction.
  • Exploration of biological processes and cell types within these networks.

Main Results:

  • Suboptimally resected tumors exhibit molecular signatures similar to a distinct EOC subtype characterized by stromal activation and lymphovascular invasion.
  • These molecular pathways are also observed in metastatic EOC, suggesting primary tumors in these patients resemble metastatic disease.
  • Genes linked to suboptimal cytoreduction are predominantly found in reactive tumor stroma cells, not malignant cells.

Conclusions:

  • Tumor biology, including extensive stromal reaction and invasiveness, significantly influences the success of cytoreductive surgery in EOC.
  • These biological factors may impede complete surgical resection, contributing to poorer patient outcomes.
  • The findings highlight the critical role of intrinsic tumor characteristics in surgical outcomes for advanced EOC.